Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141287 |
| CAS No | NA |
| Mol.F. | C16H6N4O10S2 : 2(Na) |
| Mol.Wt. | 478.4 : 2(23.0) |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141288 |
| CAS No | NA |
| Mol.F. | C16H7N3O9S2 : 2Na |
| Mol.Wt. | 449.4 : 2(23.0) |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141289 |
| CAS No | 56859-26-8 |
| Mol.F. | C10H15N3O4S |
| Mol.Wt. | 273.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141290 |
| CAS No | NA |
| Mol.F. | C14H22N2O4 |
| Mol.Wt. | 282.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141291 |
| CAS No | NA |
| Mol.F. | C16H22N6O2 |
| Mol.Wt. | 330.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141292 |
| CAS No | NA |
| Mol.F. | C4H5N3OS |
| Mol.Wt. | 143.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141293 |
| CAS No | 45590-75-8 |
| Mol.F. | C5H5N2O |
| Mol.Wt. | 109.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141294 |
| CAS No | 2514773-56-7 |
| Mol.F. | C5HCl2N5O |
| Mol.Wt. | 218.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141295 |
| CAS No | NA |
| Mol.F. | C12H14N2O2 |
| Mol.Wt. | 218.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141296 |
| CAS No | NA |
| Mol.F. | C17H20N2O4 |
| Mol.Wt. | 316.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141297 |
| CAS No | NA |
| Mol.F. | C18H22N2O4 |
| Mol.Wt. | 330.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141298 |
| CAS No | NA |
| Mol.F. | C8H11N3O |
| Mol.Wt. | 165.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141299 |
| CAS No | NA |
| Mol.F. | C10H10N2O2 |
| Mol.Wt. | 190.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141300 |
| CAS No | NA |
| Mol.F. | C8H11N3O |
| Mol.Wt. | 165.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141301 |
| CAS No | NA |
| Mol.F. | C16H18N2O4 |
| Mol.Wt. | 302.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141303 |
| CAS No | NA |
| Mol.F. | C15H16N2O4 |
| Mol.Wt. | 288.3 |
| INV STATUS | CUSTOM SYNTHESIS |